1
|
Ferri CP, Prince M, Brayne C, et al:
Global prevalence of dementia: a Delphi consensus study. Lancet.
366:2112–2117. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ballard C, Chalmers K, Todd C, et al:
Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy
bodies. Neurology. 68:1726–1729. 2007.
|
3
|
O’Brien RJ and Wong PC: Amyloid precursor
protein processing and Alzheimer’s disease. Annu Rev Neurosci.
34:185–204. 2011.
|
4
|
Duff K, Eckman C, Zehr C, et al: Increased
amyloid-beta42(43) in brains of mice expressing mutant presenilin
1. Nature. 383:710–713. 1996. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Jayadev S, Case A, Eastman AJ, et al:
Presenilin 2 is the predominant γ-secretase in microglia and
modulates cytokine release. PloS One. 5:e157432010.
|
6
|
Strittmatter WJ, Saunders AM, Schmechel D,
et al: Apolipoprotein E: high-avidity binding to beta-amyloid and
increased frequency of type 4 allele in late-onset familial
Alzheimer disease. Proc Natl Acad Sci USA. 90:1977–1981. 1993.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Parihar M and Hemnani T: Alzheimer’s
disease pathogenesis and therapeutic interventions. J Clin
Neurosci. 11:456–467. 2004.
|
8
|
Pasinetti GM: Use of cDNA microarray in
the search for molecular markers involved in the onset of
Alzheimer’s disease dementia. J Neurosci Res. 65:471–476.
2001.PubMed/NCBI
|
9
|
Blalock EM, Geddes JW, Chen KC, Porter NM,
Markesbery WR and Landfield PW: Incipient Alzheimer’s disease:
microarray correlation analyses reveal major transcriptional and
tumor suppressor responses. Proc Natl Acad Sci USA. 101:2173–2178.
2004.
|
10
|
Maes OC, Xu S, Yu B, Chertkow HM, Wang E
and Schipper HM: Transcriptional profiling of Alzheimer blood
mononuclear cells by microarray. Neurobiol Aging. 28:1795–1809.
2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Troyanskaya O, Cantor M, Sherlock G, et
al: Missing value estimation methods for DNA microarrays.
Bioinformatics. 17:520–525. 2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Fujita A, Sato JR, de Rodrigues LO,
Ferreira CE and Sogayar MC: Evaluating different methods of
microarray data normalization. BMC Bioinformatics. 7:4692006.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Pollard KS, Dudoit S and van der Laan MJ:
Multiple testing procedures: R multtest package and applications to
genomics. Bioinformatics and Computational Biology Solutions Using
R and Bioconductor. Gentleman R, Carey V, Huber W, Irizarry R and
Dudoit S: Springer; New York: pp. 251–272. 2005
|
14
|
Szklarczyk D, Franceschini A, Kuhn M, et
al: The STRING database in 2011: functional interaction networks of
proteins, globally integrated and scored. Nucleic Acid Res.
39:D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Shannon P, Markiel A, Ozier O, et al:
Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Res. 13:2498–2504. 2003.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Berriz GF, Beaver JE, Cenik C, Tasan M and
Roth FP: Next generation software for functional trend analysis.
Bioinformatics. 25:3043–3044. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hosack DA, Dennis G Jr, Sherman BT, Lane
HC and Lempicki RA: Identifying biological themes within lists of
genes with EASE. Genome Biol. 4:R702003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Balk EM, Raman G, Tatsioni A, Chung M, Lau
J and Rosenberg IH: Vitamin B6, B12, and folic acid supplementation
and cognitive function: a systematic review of randomized trials.
Arch Intern Med. 167:21–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wyss-Coray T: Inflammation in Alzheimer
disease: driving force, bystander or beneficial response? Nat Med.
12:1005–1015. 2006.PubMed/NCBI
|
20
|
Müller M, Carter S, Hofer MJ and Campbell
IL: Review: The chemokine receptor CXCR3 and its ligands CXCL9,
CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and
conundrum. Neuropathol Appl Neurobiol. 36:368–387. 2010.PubMed/NCBI
|
21
|
Salminen A, Kauppinen A, Suuronen T,
Kaarniranta K and Ojala J: ER stress in Alzheimer’s disease: a
novel neuronal trigger for inflammation and Alzheimer’s pathology.
J Neuroinflammation. 6:412009.
|
22
|
Gargalovic PS, Gharavi NM, Clark MJ, et
al: The unfolded protein response is an important regulator of
inflammatory genes in endothelial cells. Arterioscler Thromb Vasc
Biol. 26:2490–2496. 2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhang K and Kaufman RJ: From
endoplasmic-reticulum stress to the inflammatory response. Nature.
454:455–462. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Catricala S, Torti M and Ricevuti G:
Alzheimer disease and platelets: how’s that relevant. Immun Ageing.
9:202012.
|
25
|
Casserly I and Topol E: Convergence of
atherosclerosis and Alzheimer’s disease: inflammation, cholesterol,
and misfolded proteins. Lancet. 363:1139–1146. 2004.
|
26
|
Harold D, Abraham R, Hollingworth P, et
al: Genome-wide association study identifies variants at CLU and
PICALM associated with Alzheimer’s disease. Nat Genet.
41:1088–1093. 2009.
|
27
|
Lambert JC, Heath S, Even G, et al:
Genome-wide association study identifies variants at CLU and CR1
associated with Alzheimer’s disease. Nat Genet. 41:1094–1099.
2009.
|
28
|
Braskie MN, Jahanshad N, Stein JL, et al:
Common Alzheimer’s disease risk variant within the CLU gene affects
white matter microstructure in young adults. J Neurosci.
31:6764–6770. 2011.
|
29
|
Morris MC, Evans DA, Bienias JL, et al:
Dietary intake of antioxidant nutrients and the risk of incident
Alzheimer disease in a biracial community study. JAMA.
287:3230–3237. 2002. View Article : Google Scholar : PubMed/NCBI
|
30
|
Luchsinger JA and Mayeux R: Dietary
factors and Alzheimer’s disease. Lancet Neurol. 3:579–587.
2004.
|
31
|
Luchsinger JA, Noble JM and Scarmeas N:
Diet and Alzheimer’s disease. Curr Neurol Neurosci Rep. 7:366–372.
2007.
|
32
|
Liu J and Ames BN: Reducing mitochondrial
decay with mitochondrial nutrients to delay and treat cognitive
dysfunction, Alzheimer’s disease, and Parkinson’s disease. Nutr
Neurosci. 8:67–89. 2005.PubMed/NCBI
|
33
|
Lefebvre T, Dehennaut V, Guinez C, et al:
Dysregulation of the nutrient/stress sensor O-GlcNAcylation is
involved in the etiology of cardiovascular disorders, type-2
diabetes and Alzheimer’s disease. Biochim Biophys Acta. 1800:67–79.
2010.PubMed/NCBI
|
34
|
Gordon-Weeks PR and Fischer I: MAP1B
expression and microtubule stability in growing and regenerating
axons. Microsc Res Tech. 48:63–74. 2000. View Article : Google Scholar : PubMed/NCBI
|
35
|
Ulloa L, Montejo de Garcini E, Gómez-Ramos
P, Morán MA and Avila J: Microtubule-associated protein MAP1B
showing a fetal phosphorylation pattern is present in sites of
neurofibrillary degeneration in brains of Alzheimer’s disease
patients. Brain Res Mol Brain Res. 26:113–122. 1994.PubMed/NCBI
|
36
|
Hasegawa M, Arai T and Ihara Y:
Immunochemical evidence that fragments of phosphorylated MAP5
(MAP1B) are bound to neurofibrillary tangles in Alzheimer’s
disease. Neuron. 4:909–918. 1990.PubMed/NCBI
|
37
|
García-Bueno B, Caso JR and Leza JC:
Stress as a neuroinflammatory condition in brain: damaging and
protective mechanisms. Neurosci Biobehav Rev. 32:1136–1151.
2008.PubMed/NCBI
|
38
|
Hampel H, Teipel SJ, Padberg F, et al:
Discriminant power of combined cerebrospinal fluid tau protein and
of the soluble interleukin-6 receptor complex in the diagnosis of
Alzheimer’s disease. Brain Res. 823:104–112. 1999.PubMed/NCBI
|
39
|
Huppi K, Siwarski D, Pisegna J and Wank S:
Chromosomal localization of the gastric and brain receptors for
cholecystokinin (CCKAR and CCKBR) in human and mouse. Genomics.
25:727–729. 1995. View Article : Google Scholar : PubMed/NCBI
|
40
|
Wang J, Si YM, Liu ZL and Yu L:
Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B
receptor gene polymorphisms in Parkinson’s disease.
Pharmacogenetics. 13:365–369. 2003.
|
41
|
Köles L, Furst S and Illes P: P2X and P2Y
receptors as possible targets of therapeutic manipulations in CNS
illnesses. Drug News Perspect. 18:85–101. 2005.PubMed/NCBI
|
42
|
Ryu JK and McLarnon JG: Block of
purinergic P2X7 receptor is neuroprotective in an animal model of
Alzheimer’s disease. Neuroreport. 19:1715–1719. 2008.PubMed/NCBI
|
43
|
da Silva RL, Resende RR and Ulrich H:
Alternative splicing of P2X6 receptors in developing mouse brain
and during in vitro neuronal differentiation. Exp Physiol.
92:139–145. 2007.PubMed/NCBI
|